Scientists from the University of Helsinki, Aalto University, HUS Comprehensive Cancer Center, and Stanford University have designed an artificial intelligence (AI) platform capable of predicting which patients with skin cancer will gain from a treatment that triggers the immune defense system.
HELSINKI, Oct. 12 (Xinhua) A new artificial intelligence (AI) model developed in Finland is expected to help diagnose and treat skin cancer, the University of Helsinki announced on Wednesday.
The artificial intelligence model could be utilized to enable more effective care for skin cancer patients and could lead to similar breakthroughs in the diagnosis and treatment of other cancers.
A Nordic study run by HUS Comprehensive Cancer Center and the University of Helsinki examined how two different cancer treatments work better in combination rather than separately in patients.
Chronic myeloid leukemia (CML) is one of the four main types of blood cancer, and it begins in the blood-forming cells of the bone marrow. Approximately 50 Finns are diagnosed with CML each year. It typically develops in people of working age.
An international study coordinated by a University of Helsinki research group demonstrates that the body's immune system attacks itself in a rare type of blood cancer.